Eiko Lifesciences Limited is pleased to announce that company has entered into a Share Subscription Agreement (“SSA”) with “Reflux Pharmaceuticals Private Limited” (“RPPL”) in connection with the acquisition of up to 19,20,000 Equity Shares being 25.01% Equity stake in RPPL.
Eiko Lifesciences Limited is pleased to announce that company has entered into a Share Subscription Agreement (“SSA”) with “Reflux Pharmaceuticals Private Limited” (“RPPL”) in connection with the acquisition of up to 19,20,000 Equity Shares being 25.01% Equity stake in RPPL.
@LaxmikantKabra@EikoLifeScience@EconomicTimes @dcpc2017 Congratulations…💐 Sir..👏👏 If you have any fossil fuel requirement for your plant…we shall be happy to serve you….Best Regards!